ID
45518
Description
Principal Investigator: Steven Treon, MD, PhD, Dana-Farber Cancer Institute, Boston, MA, USA MeSH: Waldenstrom Macroglobulinemia https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000740 Whole genome sequencing was conducted on 10 tumor/germline paired samples along with 20 additional unpaired tumor samples from patients with Waldesntrom's macroglobulinemia. Tumor lymphoplasmacytic lymphoma cells were obtained from CD19+ selected bone marrow mononuclear cells. Germline tissue was obtained from CD19 depleted peripheral blood mononuclear cells. High molecular weight DNA was then submitted for whole genome sequencing with Complete Genomics and aligned to HG19/NCBI human reference build 37.
Link
Keywords
Versions (1)
- 12/14/22 12/14/22 - Chiara Middel
Copyright Holder
Steven Treon, MD, PhD, Dana-Farber Cancer Institute, Boston, MA, USA
Uploaded on
December 14, 2022
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
dbGaP phs000740 Whole Genome Sequencing of Waldenstrom's Macroglobulinemia
Subject ID, consent group, subject source, source subject ID, and affection status of participants with or without Waldesntrom macroglobulinemia and involved in the "Whole Genome Sequencing of Waldenstrom's Macroblulinemia".
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID, consent group, subject source, source subject ID, and affection status of participants with or without Waldesntrom macroglobulinemia and involved in the "Whole Genome Sequencing of Waldenstrom's Macroblulinemia".
- Subject ID, sample ID, sample source, sample source ID, and sample use variable associated with participants with or without Waldesntrom macroglobulinemia and involved in the "Whole Genome Sequencing of Waldenstrom's Macroblulinemia".
- Sample ID, body site where sample was obtained, analyte type, tumor status of sample, histological type of sample, and sequencing center variable associated with participants with or without Waldesntrom macroglobulinemia and involved in the "Whole Genome Sequencing of Waldenstrom's Macroblulinemia".
- Subject ID, sex, and paired germ line sample control of participants with or without Waldesntrom macroglobulinemia and involved in the "Whole Genome Sequencing of Waldenstrom's Macroblulinemia".
Similar models
Subject ID, consent group, subject source, source subject ID, and affection status of participants with or without Waldesntrom macroglobulinemia and involved in the "Whole Genome Sequencing of Waldenstrom's Macroblulinemia".
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID, consent group, subject source, source subject ID, and affection status of participants with or without Waldesntrom macroglobulinemia and involved in the "Whole Genome Sequencing of Waldenstrom's Macroblulinemia".
- Subject ID, sample ID, sample source, sample source ID, and sample use variable associated with participants with or without Waldesntrom macroglobulinemia and involved in the "Whole Genome Sequencing of Waldenstrom's Macroblulinemia".
- Sample ID, body site where sample was obtained, analyte type, tumor status of sample, histological type of sample, and sequencing center variable associated with participants with or without Waldesntrom macroglobulinemia and involved in the "Whole Genome Sequencing of Waldenstrom's Macroblulinemia".
- Subject ID, sex, and paired germ line sample control of participants with or without Waldesntrom macroglobulinemia and involved in the "Whole Genome Sequencing of Waldenstrom's Macroblulinemia".
C0441833 (UMLS CUI [1,2])
C0242481 (UMLS CUI [1,2])
C0449416 (UMLS CUI [1,2])
C0681850 (UMLS CUI [1,3])
C3847505 (UMLS CUI [1,2])
C0449416 (UMLS CUI [1,3])